WITHDRAWN: Streptococcus mutans inhibits the growth of Enterococcus via the non-ribosomal cyclic peptide mutanobactin

Insights

Streptococcus mutans produces mutanobactin, a cyclic lipopeptide, inhibiting Enterococcus faecalis growth and biofilm formation. E. faecalis resistance involves gelatinase, highlighting mutanobactin's anti-biofilm potential in polymicrobial communities.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Enterococcus faecalis is an opportunistic pathogen causing nosocomial infections, complicated by antibiotic resistance.
  • E. faecalis is linked to oral diseases and endodontic treatment failures, necessitating understanding its interactions within microbial communities.
  • The interactions between E. faecalis and oral streptococci, crucial for microbiome establishment, are not well understood.

Purpose of the Study:

  • To elucidate the mechanism by which Streptococcus mutans inhibits the growth of Enterococcus faecalis.
  • To characterize the antimicrobial compound mutanobactin and its production system.
  • To investigate the resistance mechanisms of E. faecalis against mutanobactin.

Main Methods:

  • Identification and characterization of mutanobactin, a cyclic lipopeptide produced by S. mutans.
  • Analysis of the polyketide synthase-nonribosomal peptide synthetase hybrid system (mub locus) responsible for mutanobactin production.
  • Assessment of mutanobactin's activity against planktonic and biofilm growth of E. faecalis and other Gram-positive pathogens.
  • Investigation of the role of E. faecalis virulence factor gelatinase in mutanobactin resistance.

Main Results:

  • Streptococcus mutans produces mutanobactin, a cyclic lipopeptide that inhibits planktonic and biofilm growth of E. faecalis and other Gram-positive pathogens like Staphylococcus aureus.
  • Mutanobactin damages the cell envelope of E. faecalis, similar to lipopeptide antibiotics such as daptomycin.
  • Enterococcus faecalis resistance to mutanobactin is mediated by the secreted metalloprotease gelatinase.

Conclusions:

  • Mutanobactin exhibits significant anti-biofilm potential, making it a promising natural product for therapeutic applications.
  • This study provides insights into the complex interactions within polymicrobial communities, particularly between E. faecalis and oral streptococci.
  • Understanding E. faecalis dynamics and resistance mechanisms in polymicrobial settings is crucial for managing infections and treatment failures.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
33
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
1.0K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
35
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
55
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.0K